Vijaya Diagnostic Centre Ltd

Vijaya Diagnost. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vijaya Diagnostic Centre Ltd

₹ 985 -0.44%
30 Jun - close price
vijayadiagnostic.com BSE: 543350 NSE: VIJAYA
About

Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.[1]

Key Points

Market Leadership
The company is the largest integrated diagnostic chain in South India. [1] It was among the first in South India to offer PET-CT scans. [2]

Website BSE NSE
  • Market Cap ₹ 10,116 Cr.
  • Current Price ₹ 985
  • High / Low ₹ 1,277 / 725
  • Stock P/E 70.3
  • Book Value ₹ 77.5
  • Dividend Yield 0.10 %
  • ROCE 21.7 %
  • ROE 19.8 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 12.7 times its book value
  • Working capital days have increased from 7.66 days to 63.7 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap Nifty MidSmallcap 400

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
116 104 121 113 121 121 139 133 155 156 183 169 173
68 64 72 69 72 73 82 80 92 95 107 102 104
Operating Profit 48 40 49 44 49 48 57 52 63 61 76 67 69
OPM % 41% 38% 40% 39% 41% 40% 41% 39% 41% 39% 42% 40% 40%
3 3 3 4 5 6 7 3 3 4 5 5 5
Interest 4 5 5 6 6 6 6 6 6 6 6 7 7
Depreciation 15 14 16 20 11 12 14 15 16 17 17 18 19
Profit before tax 31 24 31 22 36 35 45 35 44 42 57 47 47
Tax % 24% 26% 25% 25% 24% 26% 25% 25% 23% 25% 26% 24% 26%
24 18 23 16 28 26 34 26 34 32 42 35 35
EPS in Rs 2.33 1.71 2.29 1.60 2.69 2.57 3.26 2.53 3.27 3.06 4.09 3.43 3.38
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
251 293 339 377 462 459 548 681
171 184 206 211 259 277 327 408
Operating Profit 80 108 133 166 204 182 221 273
OPM % 32% 37% 39% 44% 44% 40% 40% 40%
7 10 15 12 13 14 19 17
Interest 5 14 15 15 16 21 24 27
Depreciation 26 40 49 50 53 62 57 71
Profit before tax 55 65 83 112 147 114 159 193
Tax % 37% 29% 25% 24% 25% 25% 25% 26%
35 46 63 85 111 85 120 144
EPS in Rs 77.44 101.29 138.00 18.64 10.76 8.29 11.61 13.94
Dividend Payout % 0% 0% 0% 0% 9% 12% 9% 14%
Compounded Sales Growth
10 Years: %
5 Years: 15%
3 Years: 14%
TTM: 24%
Compounded Profit Growth
10 Years: %
5 Years: 20%
3 Years: 10%
TTM: 34%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 41%
1 Year: 32%
Return on Equity
10 Years: %
5 Years: 21%
3 Years: 18%
Last Year: 20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 5 5 5 5 10 10 10 10
Reserves 157 203 270 354 458 535 647 785
33 146 161 141 183 248 259 320
39 53 46 41 62 61 66 158
Total Liabilities 234 406 482 541 713 853 983 1,274
119 259 272 268 370 524 742 865
CWIP 3 3 10 9 34 28 9 70
Investments 73 69 55 28 54 139 109 185
39 76 146 236 255 163 123 154
Total Assets 234 406 482 541 713 853 983 1,274

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
62 91 106 130 158 165 183 224
-98 -90 -31 -130 -123 -110 -141 -182
-8 -7 -30 -49 -31 -42 -45 -52
Net Cash Flow -44 -6 46 -49 4 13 -2 -9

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 12 11 9 6 8 8 11 8
Inventory Days 24 20 23 17 22 13 29 21
Days Payable 176 196 180 142 110 172 184 143
Cash Conversion Cycle -140 -165 -149 -118 -81 -152 -144 -114
Working Capital Days -41 -40 -38 -15 -23 -25 -16 64
ROCE % 28% 23% 27% 28% 18% 20% 22%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
55.04% 55.01% 55.01% 55.01% 54.98% 54.90% 54.87% 54.06% 53.92% 53.91% 53.91% 53.05%
27.99% 23.89% 24.96% 25.28% 20.27% 20.68% 19.95% 20.09% 20.08% 18.14% 17.54% 19.36%
12.81% 15.77% 14.22% 13.90% 19.02% 18.64% 19.82% 20.80% 21.49% 23.45% 24.62% 23.72%
4.16% 5.33% 5.79% 5.81% 5.73% 5.78% 5.36% 5.03% 4.50% 4.49% 3.92% 3.86%
No. of Shareholders 77,22976,98579,05976,53273,85072,79566,20466,72462,41562,25860,95266,891

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls